BROADWOOD CAPITAL INC
Long book
$1.42B
Q1 2026
Positions
6
Top-10 weight
100%
concentration
Last quarter
+36.1%
SPY +14.8%
Turnover
14%
of book per quarter
Strategy in plain words
auto-generated from filingsBROADWOOD CAPITAL INC is a diversified fundamental manager, running a $1.42B US long book across 6 positions.
The portfolio is extremely concentrated — the top 10 positions are almost the whole book. Turnover is modest: positions are typically held for years. Current anchor positions: MONSTER BEVERAGE CORP, STAAR SURGICAL CO, AXON ENTERPRISE INC, ISHARES RUSSELL 2000 ETF, LINEAGE CELL THERAPEUTICS IN.
Over the last 9 quarters its long book ran on average 0.2pp per quarter ahead of the S&P 500, beating the index in 3 of 9 quarters. We rate its filings as signal-bearing: position changes reflect genuine views.
Implied long-book return vs S&P 500
methodology: positions priced quarterly, no shorts/options Fund long book S&P 500
Q1 2024
-1.1%
Q2 2024
-0.6%
Q3 2024
-0.5%
Q4 2024
-6.3%
Q1 2025
+21.6%
Q2 2025
+10.2%
Q3 2025
-1.7%
Q4 2025
-15.2%
Q1 2026
+36.1%
Sector allocation
Consumer staples 45%
Healthcare 29%
Industrials 23%
Materials 3%
Long book by quarter
What does BROADWOOD CAPITAL own?
Q1 2026 13F| Company | Sector | Shares | Value | % of book | Change |
|---|---|---|---|---|---|
| MNST MONSTER BEVERAGE CORP | Consumer staples | 8.1M | $587.5M | 41.4% | -1.1% |
| STAA STAAR SURGICAL CO | Healthcare | 16.1M | $301.5M | 21.3% | +7.4% |
| AXON AXON ENTERPRISE INC | Industrials | 693.5K | $294.5M | 20.8% | Held |
| LCTX LINEAGE CELL THERAPEUTICS IN | Healthcare | 49.6M | $78.3M | 5.5% | Held |
| IMDX INSIGHT MOLECULAR DIAGNOSTIC | Materials | 11.9M | $39.1M | 2.8% | +4.6% |
13F filing history
| Period | Form | Filed | Entries | Reported value | Flags | Source |
|---|---|---|---|---|---|---|
| Q1 2026 | 13F-HR | May 15, 2026 | 6 | $1.42B | canonical | SEC ↗ |
| Q4 2025 | 13F-HR | Feb 17, 2026 | 12 | $1.70B | canonical | SEC ↗ |
| Q3 2025 | 13F-HR | Nov 14, 2025 | 12 | $1.66B | canonical | SEC ↗ |
| Q2 2025 | 13F-HR | Aug 14, 2025 | 13 | $1.57B | canonical | SEC ↗ |
| Q1 2025 | 13F-HR | May 15, 2025 | 8 | $1.23B | canonical | SEC ↗ |
| Q4 2024 | 13F-HR | Feb 14, 2025 | 7 | $1.28B | canonical | SEC ↗ |
| Q3 2024 | 13F-HR | Nov 14, 2024 | 7 | $1.30B | canonical | SEC ↗ |
| Q2 2024 | 13F-HR | Aug 14, 2024 | 7 | $1.32B | canonical | SEC ↗ |
| Q1 2024 | 13F-HR | May 15, 2024 | 7 | $1.33B | canonical | SEC ↗ |
Similar funds
DIAMANT ASSET MANAGEMENT, INC. LILLY ENDOWMENT INCBROOKFIELD Corp /ON/GQG Partners LLCMITSUBISHI UFJ FINANCIAL GROUP INCNewport Trust Company, LLCVIKING GLOBAL INVESTORS LPPARNASSUS INVESTMENTS, LLC MASTERCARD FOUNDATION ASSET MANAGEMENT CORPPZENA INVESTMENT MANAGEMENT LLCCOATUE MANAGEMENT LLCWinslow Capital Management, LLC